Nitric oxide boosters as defensive agents against COVID-19 infection: an opinion
- PMID: 33251965
- PMCID: PMC7754890
- DOI: 10.1080/07391102.2020.1852969
Nitric oxide boosters as defensive agents against COVID-19 infection: an opinion
Abstract
In the prevailing covid times, scientific community is busy in developing vaccine against COVID-19. Under such fascination this article describes the possible role of nitric oxide (NO) releasers in aiding the immune system of a human body against this dreadful pandemic disease. Despite some prodrug antiviral compounds are in practice to recover the patients suffering from covid-19, however, co-morbidity deaths are highest among the total deaths happened so far. This concurrence of a number of diseases in a patient along with this viral infection is indicative of the poor immunity. Literature background supports the use of NO as immunity boosting agent and hence, the nitric oxide releasing compounds could act as lucrative in this context. Some dietary suggestions of NO-containing food items have also been introduced in this article. Also, the profound effect of NO in relieving symptomatic severity of covid-19 has been opined in this work.Communicated by Ramaswamy H. Sarma.
Keywords: Immunity; NO; NO-release; food; synthetic moieties.
Conflict of interest statement
No conflict of interest was declared by the authors for this work
Figures
Similar articles
-
Cyanobacterial natural products as sources for antiviral drug discovery against COVID-19.J Biomol Struct Dyn. 2022 Oct;40(16):7629-7644. doi: 10.1080/07391102.2021.1899050. Epub 2021 Mar 22. J Biomol Struct Dyn. 2022. PMID: 33749496 Review.
-
Dietary foods containing nitric oxide donors can be early curators of SARS-CoV-2 infection: A possible role in the immune system.J Food Biochem. 2022 Mar;46(3):e13884. doi: 10.1111/jfbc.13884. Epub 2021 Aug 9. J Food Biochem. 2022. PMID: 34374096 Free PMC article. Review.
-
Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor.J Biomol Struct Dyn. 2021 Sep;39(15):5668-5681. doi: 10.1080/07391102.2020.1790425. Epub 2020 Jul 8. J Biomol Struct Dyn. 2021. PMID: 32643552 Free PMC article.
-
Drug repositioning against COVID-19: a first line treatment.J Biomol Struct Dyn. 2022;40(23):12812-12826. doi: 10.1080/07391102.2021.1977698. Epub 2021 Sep 14. J Biomol Struct Dyn. 2022. PMID: 34519259 Free PMC article.
-
Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.JAMA Netw Open. 2022 Aug 1;5(8):e2228900. doi: 10.1001/jamanetworkopen.2022.28900. JAMA Netw Open. 2022. PMID: 36018588 Free PMC article.
Cited by
-
Dietary xenobiotics and their role in immunomodulation.Food Sci Biotechnol. 2024 Dec 19;34(9):1805-1817. doi: 10.1007/s10068-024-01752-4. eCollection 2025 May. Food Sci Biotechnol. 2024. PMID: 40196336 Review.
-
Unraveling the impact of nitric oxide, almitrine, and their combination in COVID-19 (at the edge of sepsis) patients: a systematic review.Front Pharmacol. 2024 Jan 22;14:1172447. doi: 10.3389/fphar.2023.1172447. eCollection 2023. Front Pharmacol. 2024. PMID: 38318311 Free PMC article.
-
In silico Evaluation of NO-Sartans against SARS-CoV-2.Curr Drug Discov Technol. 2024;21(6):e050324227669. doi: 10.2174/0115701638279362240223070810. Curr Drug Discov Technol. 2024. PMID: 38445698
-
Generic model to unravel the deeper insights of viral infections: an empirical application of evolutionary graph coloring in computational network biology.BMC Bioinformatics. 2024 Feb 16;25(1):74. doi: 10.1186/s12859-024-05690-0. BMC Bioinformatics. 2024. PMID: 38365632 Free PMC article.
-
Development of Metal Complexes for Treatment of Coronaviruses.Int J Mol Sci. 2022 Jun 8;23(12):6418. doi: 10.3390/ijms23126418. Int J Mol Sci. 2022. PMID: 35742870 Free PMC article.
References
-
- Bates, J. N., Baker, M. T., Guerra, R., Jr., & Harrison, D. G. (1991). Nitric oxide generation from nitroprusside by vascular tissue: Evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochemical Pharmacology, 42, S157–S165. 10.1016/0006-2952(91)90406-U - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical